BACKGROUND: Reperfusion injury is a common clinical problem that lacks effective therapy. Two decades of research implicating oxygen free radicals and neutrophils has not led to a single successful clinical trial. METHODS: The aim was to review new clinical and preclinical data pertaining to the alleviation of reperfusion injury. A review of the literature was undertaken by searching the MEDLINE database for the period 1966-2003 without language restrictions. RESULTS AND CONCLUSION: Evidence now points to complement and immune complexes as critical players in mediating reperfusion injury. Ischaemia is postulated to induce a phenotypical cellular change through the surface expression of a neoantigen. Preformed circulating natural IgM antibodies are then trapped and complement is activated. Final events leading to reperfusion injury include formation of the membrane attack complex and mast cell degranulation. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
BACKGROUND:Reperfusion injury is a common clinical problem that lacks effective therapy. Two decades of research implicating oxygen free radicals and neutrophils has not led to a single successful clinical trial. METHODS: The aim was to review new clinical and preclinical data pertaining to the alleviation of reperfusion injury. A review of the literature was undertaken by searching the MEDLINE database for the period 1966-2003 without language restrictions. RESULTS AND CONCLUSION: Evidence now points to complement and immune complexes as critical players in mediating reperfusion injury. Ischaemia is postulated to induce a phenotypical cellular change through the surface expression of a neoantigen. Preformed circulating natural IgM antibodies are then trapped and complement is activated. Final events leading to reperfusion injury include formation of the membrane attack complex and mast cell degranulation. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Authors: Anne-Maud Burk; Myriam Martin; Michael A Flierl; Daniel Rittirsch; Matthias Helm; Lorenz Lampl; Uwe Bruckner; Gregory L Stahl; Anna M Blom; Mario Perl; Florian Gebhard; Markus Huber-Lang Journal: Shock Date: 2012-04 Impact factor: 3.454
Authors: G J Arason; J Kramer; B Blaskó; R Kolka; P Thorbjornsdottir; K Einarsdóttir; A Sigfúsdóttir; S T Sigurdarson; G Sigurdsson; Z Rónai; Z Prohászka; M Sasvári-Székely; S Bödvarsson; G Thorgeirsson; G Füst Journal: Clin Exp Immunol Date: 2007-04-11 Impact factor: 4.330
Authors: B H M Heijnen; I H Straatsburg; N D Padilla; G J Van Mierlo; C E Hack; T M Van Gulik Journal: Clin Exp Immunol Date: 2006-01 Impact factor: 4.330
Authors: Constantin Mayer; Alexander Franz; Jan-Frieder Harmsen; Fina Queitsch; Michael Behringer; Johannes Beckmann; Rüdiger Krauspe; Christoph Zilkens Journal: J Orthop Date: 2017-06-24
Authors: Tushar A Shah; Jasmine E Nejad; Haree K Pallera; Frank A Lattanzio; Rawad Farhat; Parvathi S Kumar; Pamela S Hair; W Thomas Bass; Neel K Krishna Journal: Pediatr Res Date: 2016-12-21 Impact factor: 3.756
Authors: Eric G Sheu; Sean M Oakes; Cyrus Ahmadi-Yazdi; Jalil Afnan; Michael C Carroll; Francis D Moore Journal: Surgery Date: 2009-08 Impact factor: 3.982
Authors: Daniel Schmitz; Joerg M Bangen; Christoph U Herborn; Baher Husain; Sven Lendemans; Stefanie B Flohé; Klaus A Metz; F Ulrich Schade; Georg Taeger; Jörg R Oberbeck; Philipp Kobbe; Christian Waydhas; Sascha Flohé Journal: Inflamm Res Date: 2009-08-26 Impact factor: 4.575